INT249
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
In summary, alpha 2-adrenergic agonism appears to act primarily in GH control by inhibiting the hypothalamic release of somatostatin, rather than by stimulating GHRH secretion. | |||||||||||||||
| |||||||||||||||
|
Opioid-receptor blockade blunts growth hormone (GH) secretion induced by GH-releasing hormone in the human male. | |||||||||||||||
| |||||||||||||||
|
OBJECTIVE: To investigate the existence of an opioid stimulatory tone on growth hormone (GH) secretion in the human male. | |||||||||||||||
| |||||||||||||||
|
The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man. | |||||||||||||||
| |||||||||||||||
|
Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. | |||||||||||||||
| |||||||||||||||
|
The stimulatory effect of clonidine on GH secretion has been suggested to depend on an enhancement of hypothalamic GH-releasing hormone (GHRH) release. | |||||||||||||||
| |||||||||||||||
|
One group received fentanyl 15 micrograms kg-1 i.v. immediately before the start of surgery; a second group received fentanyl 15 micrograms kg-1 i.v. together with corticotrophin releasing factor 100 micrograms i.v., growth hormone releasing hormone 100 micrograms i.v. and arginine vasopressin 10 units i.m. | |||||||||||||||
| |||||||||||||||
|
One group received fentanyl 15 micrograms kg-1 i.v. immediately before the start of surgery; a second group received fentanyl 15 micrograms kg-1 i.v. together with corticotrophin releasing factor 100 micrograms i.v., growth hormone releasing hormone 100 micrograms i.v. and arginine vasopressin 10 units i.m. | |||||||||||||||
| |||||||||||||||
|
She also had hyperprolactinaemia and decreased human growth hormone secretion. | |||||||||||||||
| |||||||||||||||
|
This action is probably mediated at the level of the hypothalamus, where the drug may act through inhibition of somatostatin (SRIH) and/or stimulation of GH-releasing hormone (GHRH) release. | |||||||||||||||
| |||||||||||||||
|
This action is probably mediated at the level of the hypothalamus, where the drug may act through inhibition of somatostatin (SRIH) and/or stimulation of GH-releasing hormone (GHRH) release. | |||||||||||||||
| |||||||||||||||
|
Growth hormone secretion in children with normal variants of short stature. | |||||||||||||||
| |||||||||||||||
|
Opioids stimulate growth hormone (GH) release in man independently of GH-releasing hormone. | |||||||||||||||
| |||||||||||||||
|
Two patients with propionic acidemia had decreased growth hormone secretion in response to provocative stimuli (intravenous L-arginine and oral levodopa or clonidine); the remaining subjects had sufficient growth hormone secretion. | |||||||||||||||
| |||||||||||||||
|
Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumors. | |||||||||||||||
| |||||||||||||||
|
The acute administration of glucocorticoids is a new stimulus of growth hormone (GH) secretion in man. | |||||||||||||||
| |||||||||||||||
|
Corticoid-induced growth hormone (GH) secretion in GH-deficient and normal children. | |||||||||||||||
| |||||||||||||||
|
Growth hormone secretion in response to the new centrally acting antihypertensive agent moxonidine in normal human subjects: comparison to clonidine and GHRH. | |||||||||||||||
| |||||||||||||||
|
This effect is most likely due to stimulation of hypothalamic growth hormone releasing hormone (GHRH) release. | |||||||||||||||
| |||||||||||||||
|
It is well established that the central alpha 2-adrenergic agonist clonidine can enhance growth hormone (GH) secretion in humans. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.